GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 733 filers reported holding GLAXOSMITHKLINE PLC in Q4 2014. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $243,000 | +18.0% | 6,450 | +22.2% | 0.06% | -13.7% |
| Q1 2018 | $206,000 | -53.4% | 5,279 | -51.5% | 0.07% | -55.5% |
| Q3 2017 | $442,000 | -8.3% | 10,890 | -2.6% | 0.16% | -14.1% |
| Q2 2017 | $482,000 | +1.7% | 11,184 | -0.5% | 0.19% | -3.5% |
| Q1 2017 | $474,000 | +7.7% | 11,239 | -1.7% | 0.20% | 0.0% |
| Q4 2016 | $440,000 | +0.9% | 11,436 | +13.1% | 0.20% | -8.8% |
| Q3 2016 | $436,000 | +14.1% | 10,107 | +14.8% | 0.22% | +6.4% |
| Q2 2016 | $382,000 | +32.2% | 8,807 | +23.4% | 0.20% | +30.8% |
| Q1 2016 | $289,000 | +6.2% | 7,135 | +5.9% | 0.16% | +4.0% |
| Q4 2015 | $272,000 | -6.5% | 6,735 | -10.9% | 0.15% | -16.2% |
| Q3 2015 | $291,000 | -11.6% | 7,560 | -4.2% | 0.18% | -0.6% |
| Q2 2015 | $329,000 | +0.3% | 7,890 | +10.9% | 0.18% | -4.8% |
| Q1 2015 | $328,000 | -34.1% | 7,113 | -38.9% | 0.19% | -28.7% |
| Q4 2014 | $498,000 | – | 11,645 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |